SSP Of Japan Now 93 Percent Owned By German Drug Maker
This article was originally published in PharmAsia News
Executive Summary
Japan's SSP has become at least 93 percent owned by German drug maker Boehringer Ingelheim, almost enough to make SSP part of a holding company of the investor. SSP is Japan's third-largest producer of over-the-counter drugs, specializing in those considered easy to take. Boehringer Ingelheim expects to increase its stake in SSP to nearly 94 percent, at which point the German firm would take SSP off the stock market. (Click here for more - a subscription may be required